{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:04:38Z","timestamp":1792047878995,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","anesthesiahistoryjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anesthesia History"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.janh.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T22:30:22Z","timestamp":1496529022000},"page":"87-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Beyond Ether and Chloroform\u2014A Major Breakthrough With Halothane"],"prefix":"10.1016","volume":"3","author":[{"given":"Lisa","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.janh.2017.05.003_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2307\/1251472","article-title":"The product life cycle: analysis and application issues","volume":"45","author":"Day","year":"1981","journal-title":"J Mark"},{"key":"10.1016\/j.janh.2017.05.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-12-56","article-title":"Adoption of new drugs by physicians: a survival analysis","volume":"12","author":"Garjon","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.janh.2017.05.003_bb0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ps.201200186","article-title":"How quickly do physicians adopt new drugs? The case of second generation antipsychotics","volume":"64","author":"Huskamp","year":"2013","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.janh.2017.05.003_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-14-469","article-title":"Factors affecting the uptake of new medicines: a systematic literature review","volume":"14","author":"Lubloy","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.janh.2017.05.003_bb0025","series-title":"How Does FDA Decide When a Drug Is Not Safe Enough to Stay on the Market?","author":"FDA","year":"2016"},{"key":"10.1016\/j.janh.2017.05.003_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R & D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J Health Econ"},{"key":"10.1016\/j.janh.2017.05.003_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.healthpol.2010.12.002","article-title":"The cost of drug development: a systematic review","volume":"100","author":"Morgan","year":"2011","journal-title":"Health Policy"},{"issue":"9296","key":"10.1016\/j.janh.2017.05.003_bb0040","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0140-6736(01)06891-X","article-title":"Industry-sponsored clinical research: a double-edged sword","volume":"358","author":"Montaner","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.janh.2017.05.003_bb0045","series-title":"Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients","author":"Goldacre","year":"2013"},{"key":"10.1016\/j.janh.2017.05.003_bb0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/bja\/72.6.710","article-title":"A short history of fires and explosions caused by anaesthetic agents","volume":"72","author":"Macdonald","year":"1994","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.janh.2017.05.003_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2044.1965.tb02511.x","article-title":"Post-operative vomiting after ether-air anaesthesia","volume":"20","author":"Holmes","year":"1965","journal-title":"Anaesthesia"},{"key":"10.1016\/j.janh.2017.05.003_bb0060","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.287.10.1233","article-title":"Postoperative nausea and vomiting\u2014can it be eliminated?","volume":"287","author":"Gan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.janh.2017.05.003_bb0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00000542-195807000-00010","article-title":"Postanesthetic nausea, retching, and vomiting; evaluation of cyclizine (Marezine) suppositories for treatment","volume":"19","author":"Bonica","year":"1958","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0041-008X(74)90068-4","article-title":"The role of metabolism in chloroform hepatotoxicity","volume":"29","author":"Lavigne","year":"1974","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.janh.2017.05.003_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-4800(76)90053-8","article-title":"The role of glutathione in chloroform-induced hepatotoxicity","volume":"24","author":"Docks","year":"1976","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.janh.2017.05.003_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1476-5381.1951.tb00617.x","article-title":"Susceptibility to ventricular fibrillation during chloroform and cyclopropane anaesthesia","volume":"6","author":"Hutcheon","year":"1951","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.janh.2017.05.003_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2344\/0003-3006-55.4.124","article-title":"Nitrous oxide and the inhalation anesthetics","volume":"55","author":"Becker","year":"2008","journal-title":"Anesth Prog"},{"key":"10.1016\/j.janh.2017.05.003_bb0090","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/00000542-199404000-00024","article-title":"New inhaled anesthetics","volume":"80","author":"Eger","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bpa.2005.03.002","article-title":"Nitrous oxide: a unique drug of continuing importance for anesthesia","volume":"19","author":"Hopkins","year":"2005","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.janh.2017.05.003_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1213\/00000539-192901000-00030","article-title":"Minimizing the fire and explosion hazard of anesthetic agents","volume":"8","author":"Wardell","year":"1929","journal-title":"Anesth Analg"},{"key":"10.1016\/j.janh.2017.05.003_bb0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/bja\/46.8.613","article-title":"Drug interactions in anaesthesia","volume":"46","author":"Grogono","year":"1974","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.janh.2017.05.003_bb0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/bmj.1.5641.422","article-title":"Trichloroethylene neuropathy","author":"Mitchell","year":"1969","journal-title":"Br Med J"},{"key":"10.1016\/j.janh.2017.05.003_bb0115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0002-9149(60)90217-4","article-title":"The effects of anesthesia upon the heart","volume":"6","author":"Etsten","year":"1960","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.janh.2017.05.003_bb0120","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.RES.8.5.948","article-title":"Cardiac arrhythmias induced by minimal doses of epinephrine in cyclopropane-anesthetized dogs","volume":"8","author":"Dresel","year":"1960","journal-title":"Circ Res"},{"key":"10.1016\/j.janh.2017.05.003_bb0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/10408440802237664","article-title":"Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons?","volume":"38","author":"Himmel","year":"2008","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.janh.2017.05.003_bb0130","series-title":"A Synopsis of Anaesthesia","author":"Lee","year":"1973"},{"key":"10.1016\/j.janh.2017.05.003_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00000542-194107000-00003","article-title":"Unsaturated mono halogenated hydrocarbons as general anesthetic agents","volume":"2","author":"Abreu","year":"1941","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00000542-195309000-00006","article-title":"Anesthesia. XLI: the anesthetic properties of certain fluorinated hydrocarbons and ethers","volume":"14","author":"Lu","year":"1953","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-3565(25)07824-3","article-title":"Preliminary studies on the anesthetic activity of fluorinated hydrocarbons","volume":"86","author":"Robbins","year":"1946","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.janh.2017.05.003_bb0150","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/bja\/29.10.466","article-title":"Some chemical and physical factors in the development of fluothane","volume":"29","author":"Suckling","year":"1957","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.janh.2017.05.003_bb0155","author":"Suckling"},{"key":"10.1016\/j.janh.2017.05.003_bb0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1476-5381.1956.tb00007.x","article-title":"The action of fluothane; a new volatile anaesthetic","volume":"11","author":"Raventos","year":"1956","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.janh.2017.05.003_bb0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00000542-196107000-00013","article-title":"Halothane: the first five years","volume":"22","author":"Johnstone","year":"1961","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0170","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/bmj.2.4999.969","article-title":"Fluothane: a non-explosive volatile anesthetic agent","volume":"2","author":"Bryce-Smith","year":"1956","journal-title":"Br Med J"},{"key":"10.1016\/j.janh.2017.05.003_bb0175","series-title":"A Practice of Anaesthesia","author":"Wylie","year":"1960"},{"key":"10.1016\/j.janh.2017.05.003_bb0180","series-title":"Practical Anesthesiology","author":"Artusio","year":"1962"},{"key":"10.1016\/j.janh.2017.05.003_bb0185","series-title":"Anaesthesiology","author":"Hale","year":"1963"},{"key":"10.1016\/j.janh.2017.05.003_bb0190","series-title":"Techniques and Procedures of Anesthesia","author":"Adriani","year":"1964"},{"key":"10.1016\/j.janh.2017.05.003_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000542-196301000-00005","article-title":"Halothane anesthesia as a possible cause of massive hepatic necrosis","volume":"24","author":"Brody","year":"1963","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM196303072681005","article-title":"Liver necrosis after halothane anesthesia. Cause or coincidence?","volume":"268","author":"Bunker","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.janh.2017.05.003_bb0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM196903062801001","article-title":"Recurrent hepatitis attributable to halothane sensitization in an anesthetist","volume":"280","author":"Klatskin","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.janh.2017.05.003_bb0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00132586-196308000-00038","article-title":"Influence of hypercarbia and hypotension upon liver damage following halothane anaesthesia","volume":"7","author":"Morris","year":"1963","journal-title":"Surv Anesthesiol"},{"key":"10.1016\/j.janh.2017.05.003_bb0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-195805000-00001","article-title":"Anesthetic, circulatory and respiratory effects of fluothane","volume":"19","author":"Burnap","year":"1958","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0220","first-page":"712","article-title":"The effects of fluothane, cyclopropane, and ether anesthesias on liver function","volume":"107","author":"Little","year":"1958","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.janh.2017.05.003_bb0225","series-title":"The Pharmacological Basis of Therapeutics","author":"Goodman","year":"1965"},{"key":"10.1016\/j.janh.2017.05.003_bb0230","series-title":"The Pharmacological Basis of Therapeutics","author":"Goodman","year":"1970"},{"key":"10.1016\/j.janh.2017.05.003_bb0235","series-title":"National Halothane Study: A Study of the Possible Association Between Halothane Anesthesia and Postoperative Hepatic Necrosis","author":"Council","year":"1969"},{"key":"10.1016\/j.janh.2017.05.003_bb0240","series-title":"Principles of Anesthesiology","author":"Collins","year":"1976"},{"key":"10.1016\/j.janh.2017.05.003_bb0245","series-title":"The Pharmacological Basis of Therapeutics","author":"Gilman","year":"1980"},{"key":"10.1016\/j.janh.2017.05.003_bb0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1213\/00000539-196411000-00024","article-title":"Urinary excretion of bromide in halothane anesthesia","volume":"43","author":"Stier","year":"1964","journal-title":"Anesth Analg"},{"key":"10.1016\/j.janh.2017.05.003_bb0255","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(25)24104-0","article-title":"Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane","volume":"245","author":"Kenna","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.janh.2017.05.003_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0022-1759(84)90219-9","article-title":"An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens","volume":"75","author":"Kenna","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.janh.2017.05.003_bb0265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1213\/00000539-200202000-00003","article-title":"Autoantibodies associated with volatile anesthetic hepatitis found in the sera of large cohort of pediatric anesthesiologists","volume":"94","author":"Njoku","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.janh.2017.05.003_bb0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1213\/00000539-200202000-00001","article-title":"Good news, bad news","volume":"94","author":"Eger","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.janh.2017.05.003_bb0275","series-title":"Pharmaceutical Manufacturing Encyclopedia","author":"Sittig","year":"2007"},{"key":"10.1016\/j.janh.2017.05.003_bb0280","series-title":"Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants","author":"Barceloux","year":"2012"},{"key":"10.1016\/j.janh.2017.05.003_bb0285","series-title":"The History of Wyeth Pharmaceuticals","year":"2009"},{"key":"10.1016\/j.janh.2017.05.003_bb0290","series-title":"Wyeth: A History Through Artifacts (Marvin Samson Center for the History of Pharmacy, University of the Sciences, Philadelphia)","year":"2015"},{"key":"10.1016\/j.janh.2017.05.003_bb0295","series-title":"Pfizer Inc: Exploring Our History. 2000-Present","year":"2016"},{"key":"10.1016\/j.janh.2017.05.003_bb0300","first-page":"689","article-title":"The first anesthesia records (Codman, Cushing)","volume":"71","author":"Beecher","year":"1940","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.janh.2017.05.003_bb0305","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00000542-199904000-00019","article-title":"Awareness during anesthesia: a closed claim analysis","volume":"90","author":"Domino","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.janh.2017.05.003_bb0310","series-title":"British Pharmacopoeia","author":"General Medical Council","year":"1963"},{"key":"10.1016\/j.janh.2017.05.003_bb0315","series-title":"British Pharmaceutical Codex","author":"Council of the Pharmaceutical Society of Great Britain","year":"1959"},{"key":"10.1016\/j.janh.2017.05.003_bb0320","series-title":"Anesthesia for Infants and Children (4th)","author":"Smith","year":"1980"},{"key":"10.1016\/j.janh.2017.05.003_bb0325","first-page":"357","article-title":"Anaesthetic management in asthma","volume":"73","author":"Burburan","year":"2007","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.janh.2017.05.003_bb0330","author":"World Health Organization"},{"key":"10.1016\/j.janh.2017.05.003_bb0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0447.2010.01650.x","article-title":"The need for publishing the silent evidence from negative trials","volume":"123","author":"Colom","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.janh.2017.05.003_bb0340","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jama.1990.03440100097014","article-title":"The existence of publication bias and risk factors for its occurence","volume":"263","author":"Dickersin","year":"1990","journal-title":"JAMA"}],"container-title":["Journal of Anesthesia History"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352452917300026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352452917300026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:38:21Z","timestamp":1750289901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352452917300026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2352452917300026"],"URL":"https:\/\/doi.org\/10.1016\/j.janh.2017.05.003","relation":{},"ISSN":["2352-4529"],"issn-type":[{"value":"2352-4529","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Ether and Chloroform\u2014A Major Breakthrough With Halothane","name":"articletitle","label":"Article Title"},{"value":"Journal of Anesthesia History","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janh.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Anesthesia History Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}